243 related articles for article (PubMed ID: 29361459)
21. Once versus twice daily injection of enoxaparin for thromboprophylaxis in bariatric surgery: effects on antifactor Xa activity and procoagulant microparticles. A randomized controlled study.
Steib A; Degirmenci SE; Junke E; Asehnoune K; Figier M; Pericard C; Rohr S; Letessier E; Brunaud L; Vix M; Zobairi F; Grunebaum L; Toti F
Surg Obes Relat Dis; 2016; 12(3):613-621. PubMed ID: 26686309
[TBL] [Abstract][Full Text] [Related]
22. Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery.
Magee CJ; Barry J; Javed S; Macadam R; Kerrigan D
Surg Obes Relat Dis; 2010; 6(3):322-5. PubMed ID: 20510295
[TBL] [Abstract][Full Text] [Related]
23. Duration of surgery independently influences risk of venous thromboembolism after laparoscopic bariatric surgery.
Chan MM; Hamza N; Ammori BJ
Surg Obes Relat Dis; 2013; 9(1):88-93. PubMed ID: 22055389
[TBL] [Abstract][Full Text] [Related]
24. Adding a Preoperative Dose of LMWH may Decrease VTE Following Bariatric Surgery.
Abdelsalam AM; ElAnsary AMSE; Salman MA; Nassef SA; Elfergany HM; Aisha HAA
World J Surg; 2021 Jan; 45(1):126-131. PubMed ID: 32989579
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic Use of Enoxaparin in Adolescents During Bariatric Surgery-a Prospective Clinical Study.
Vaughns JD; Ziesenitz VC; Williams EF; Nadler EP; Mikus G; van den Anker J
Obes Surg; 2020 Jan; 30(1):63-68. PubMed ID: 31463801
[TBL] [Abstract][Full Text] [Related]
26. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ
Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998
[TBL] [Abstract][Full Text] [Related]
27. Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study).
Imberti D; Baldini E; Pierfranceschi MG; Nicolini A; Cartelli C; De Paoli M; Boni M; Filippucci E; Cariani S; Bottani G
Obes Surg; 2014 Feb; 24(2):284-91. PubMed ID: 24163189
[TBL] [Abstract][Full Text] [Related]
28. Monitoring anti-Xa levels in elderly medical patients undergoing thromboprophylaxis: A prospective cohort study.
Papazachariou A; Papadakis JA; Malikides V; Nikiforou A; Alexiadou D; Malikides O; Ioannou P; Ximeri M; Kofteridis DP
Geriatr Gerontol Int; 2024 Jun; 24(6):587-594. PubMed ID: 38705573
[TBL] [Abstract][Full Text] [Related]
29. Underdosing of Prophylactic Enoxaparin Is Common in Orthopaedic Trauma and Predicts 90-Day Venous Thromboembolism.
Jones DL; Jones WA; Fleming KI; Higgins TF; Rothberg DL; Zhang Y; Pannucci CJ
J Orthop Trauma; 2019 Nov; 33(11):570-576. PubMed ID: 31634287
[TBL] [Abstract][Full Text] [Related]
30. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study.
Hamad GG; Choban PS
Obes Surg; 2005; 15(10):1368-74. PubMed ID: 16354513
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery.
Simone EP; Madan AK; Tichansky DS; Kuhl DA; Lee MD
Surg Endosc; 2008 Nov; 22(11):2392-5. PubMed ID: 18594915
[TBL] [Abstract][Full Text] [Related]
32. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
Yam L; Bahjri K; Geslani V; Cotton A; Hong L
Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
[TBL] [Abstract][Full Text] [Related]
33. Thromboembolic Prophylaxis for Morbidly Obese Patients Undergoing Bariatric Surgery.
Ruiz-Tovar J; Llavero C
Adv Exp Med Biol; 2017; 906():9-13. PubMed ID: 27628003
[TBL] [Abstract][Full Text] [Related]
34. Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study.
Froehling DA; Daniels PR; Mauck KF; Collazo-Clavell ML; Ashrani AA; Sarr MG; Petterson TM; Heit JA
Obes Surg; 2013 Nov; 23(11):1874-9. PubMed ID: 24022324
[TBL] [Abstract][Full Text] [Related]
35. Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial.
Alalaf SK; Jawad RK; Muhammad PR; Ali MS; Al Tawil NG
BMC Pregnancy Childbirth; 2015 Mar; 15():72. PubMed ID: 25884460
[TBL] [Abstract][Full Text] [Related]
36. Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis.
Chapman TM; Goa KL
Drugs; 2003; 63(21):2357-77. PubMed ID: 14524738
[TBL] [Abstract][Full Text] [Related]
37. A New Protocol for Venous Thromboembolism Prophylaxis in Bariatric Surgery.
Abuoglu HH; Müftüoğlu MAT; Odabaşı M
Obes Surg; 2019 Feb; 29(2):729-734. PubMed ID: 30542826
[TBL] [Abstract][Full Text] [Related]
38. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels Compared with Recommended Thromboprophylaxis and Rates of Clinically Evident Venous Thromboembolism in Surgical Oncology Patients.
Kramme K; Sarraf P; Munene G
J Am Coll Surg; 2020 Mar; 230(3):314-321. PubMed ID: 31843692
[TBL] [Abstract][Full Text] [Related]
40. Practice patterns in high-risk bariatric venous thromboembolism prophylaxis.
Pryor HI; Singleton A; Lin E; Lin P; Vaziri K
Surg Endosc; 2013 Mar; 27(3):843-8. PubMed ID: 23052502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
